Bioharvest Sciences Inc (BHST) Stock Price, Quote & News

Company Profile

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and function...

Industry: Packaged Foods

Sector: Consumer Defensive

Phone: 604 689 5722

Fax: 604 685 9182

Website: www.bioharvest.com

Address:

1140-625 Howe Street, Vancouver, Canada

sepsis74 Feb. 2 at 9:43 PM

$BHST the lock-up from the November 7 offering at $7 expires on Feb. 5th. Is that what all the constant weakness has been about? Those guys aren't going to sell. There isn't enough liquidity for that. And they are down -30%.

0 · Reply

forgottenchuck Jan. 30 at 7:52 PM

$BHST CRICKETS AS USUALL

0 · Reply

hBarbarism Jan. 28 at 8:51 PM

$BHST Yes partnership with Gatorade , Let’s goo

0 · Reply

sepsis74 Jan. 28 at 2:17 PM

$BHST all good news, but the stock is languishing.

1 · Reply

mankind1 Jan. 28 at 1:05 AM

$BHST I was thinking... these drinks and chewables can be really big. I'd imagine Gatorade would be interested in working with them.

0 · Reply

OfficialStocktwitsUser Jan. 25 at 3:30 AM

$BHST RSI: 57.58, MACD: -0.1615 Vol: 0.24, MA20: 5.23, MA50: 5.82 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

mankind1 Jan. 8 at 5:12 PM

$BHST somebody give me something to think about

1 · Reply

mankind1 Jan. 7 at 8:44 PM

$BHST getting some attention

0 · Reply

BioHarvest_Sciences Jan. 7 at 4:42 PM

$BHST News Release--> BioHarvest Issues Year End CEO Shareholder Letter. "2025 marked an important milestone for BioHarvest Sciences: our first full year as a NASDAQ-listed company, and we enter 2026 with an annualized revenue run rate exceeding US$36 million and gross margins above 60%..." Read full letter: https://bioharvest.com/bioharvest-sciences-issues-year-end-shareholder-letter/

0 · Reply

newsfile_corp Jan. 7 at 12:31 PM

https://nfne.ws/279690 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #AnnualResults #NASDAQ #In

0 · Reply

BioHarvest Sciences Issues Year End Shareholder Letter

Dec 18, 2025, 7:30 AM EST - 6 weeks ago

BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform

Dec 3, 2025, 7:30 AM EST - 2 months ago

BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product

Nov 13, 2025, 11:11 PM EST - 2 months ago

BioHarvest Sciences Inc. (BHST) Q3 2025 Earnings Call Transcript

Nov 13, 2025, 4:05 PM EST - 2 months ago

BioHarvest Sciences Reports Third Quarter 2025 Financial Results

Nov 12, 2025, 8:42 AM EST - 3 months ago

BioHarvest Sciences to Attend the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025

Nov 10, 2025, 4:18 PM EST - 3 months ago

BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter's Option to Purchase Additional Shares

Nov 7, 2025, 7:30 AM EST - 3 months ago

BioHarvest Sciences Announces Pricing of $17.4 Million Upsized Public Offering of Common Stock

Nov 6, 2025, 4:37 PM EST - 3 months ago

BioHarvest Announces Proposed Public Offering of Common Stock

Nov 4, 2025, 7:30 AM EST - 3 months ago

BioHarvest Sciences to Host Third Quarter Earnings Call on November 13 at 4:30 p.m. Eastern Time

Oct 30, 2025, 7:30 AM EDT - 3 months ago

BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis

Sep 22, 2025, 6:32 AM EDT - 4 months ago

BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and Additional $3.8 Million in Debt Reduction

Sep 10, 2025, 7:45 PM EDT - 5 months ago

BioHarvest Sciences Inc. (BHST) Virtual Investor Webinar Call (Transcript)

Sep 10, 2025, 7:00 AM EDT - 5 months ago

BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale

Sep 2, 2025, 8:30 AM EDT - 5 months ago

BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ET

Aug 11, 2025, 1:20 PM EDT - 6 months ago

BioHarvest Sciences Inc. (BHST) Q2 2025 Earnings Call Transcript

Aug 11, 2025, 7:30 AM EDT - 6 months ago

BioHarvest Sciences Reports Second Quarter 2025 Financial Results

Aug 4, 2025, 8:30 AM EDT - 6 months ago

BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. Eastern Time

Jul 23, 2025, 8:30 AM EDT - 7 months ago

BioHarvest Sciences to Present at Canaccord Genuity 45th Annual Growth Conference on August 12-14, 2025

Jun 4, 2025, 7:00 AM EDT - 8 months ago

BioHarvest Launches Informed Sport-Certified VINIA DailyChews 2X Formula for Athletes and People with Active Lifestyles

May 21, 2025, 8:30 AM EDT - 9 months ago

BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound

May 15, 2025, 11:18 PM EDT - 9 months ago

BioHarvest Sciences Inc. (BHST) Q1 2025 Earnings Call Transcript

May 15, 2025, 4:05 PM EDT - 9 months ago

BioHarvest Sciences Reports First Quarter 2025 Financial Results

May 12, 2025, 8:30 AM EDT - 9 months ago

BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company

May 1, 2025, 8:30 AM EDT - 9 months ago

BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time

Mar 31, 2025, 8:54 PM EDT - 11 months ago

BioHarvest Sciences Inc. (BHST) Q4 2024 Earnings Conference Call Transcript

Mar 31, 2025, 4:05 PM EDT - 11 months ago

BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 17, 2025, 8:30 AM EDT - 11 months ago

BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time

Mar 6, 2025, 8:30 AM EST - 11 months ago

BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025

Mar 4, 2025, 8:30 AM EST - 1 year ago

BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells

Feb 18, 2025, 8:30 AM EST - 1 year ago

BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD

Feb 12, 2025, 8:30 AM EST - 1 year ago

BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18

Jan 22, 2025, 8:30 AM EST - 1 year ago

BioHarvest Announces Appointment of Sharon Malka to Board of Directors

Jan 8, 2025, 8:41 AM EST - 1 year ago

BioHarvest Issues Shareholder Letter and Provides Corporate Update

Dec 11, 2024, 6:00 AM EST - 1 year ago

Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology

Nov 25, 2024, 7:01 PM EST - 1 year ago

BioHarvest Sciences Inc. (BHST) Q3 2024 Earnings Call Transcript

Nov 25, 2024, 4:05 PM EST - 1 year ago

BioHarvest Sciences Reports Third Quarter 2024 Financial Results

Nov 25, 2024, 8:30 AM EST - 1 year ago

BioHarvest Launches VINIA SuperFood Functional Tea Line

Nov 21, 2024, 8:30 AM EST - 1 year ago

BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024

Nov 18, 2024, 8:30 AM EST - 1 year ago

BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time

Nov 12, 2024, 8:30 AM EST - 1 year ago

BioHarvest Sciences Begins Trading on the Nasdaq Global Market

Nov 7, 2024, 8:30 AM EST - 1 year ago

BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market

Oct 23, 2024, 8:30 AM EDT - 1 year ago

BioHarvest Sciences Announces Record Preliminary Third Quarter 2024 Financial Results

Oct 16, 2024, 8:47 AM EDT - 1 year ago

BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024

Sep 20, 2024, 8:30 AM EDT - 1 year ago

BioHarvest Sciences Reports Director's Ongoing Key Role Following Resignation from Board

Sep 12, 2024, 8:30 AM EDT - 1 year ago

BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on September 24-25, 2024

Sep 4, 2024, 8:30 AM EDT - 1 year ago

BioHarvest Sciences to Present at H.C. Wainwright 26th Annual Global Investment Conference

Aug 29, 2024, 9:22 AM EDT - 1 year ago

BioHarvest Sciences Reports Record Second Quarter 2024 Financial Results

Aug 28, 2024, 9:56 AM EDT - 1 year ago

BioHarvest Sciences Surpasses USD $1.0 Million in Cumulative Direct Sales of Coffee with VINIA Inside

Aug 23, 2024, 8:30 AM EDT - 1 year ago

BioHarvest Sciences to Host Second Quarter 2024 Corporate Update Call on August 29, 2024, at 2:30 p.m. Eastern Time

sepsis74 Feb. 2 at 9:43 PM

0 · Reply

forgottenchuck Jan. 30 at 7:52 PM

$BHST CRICKETS AS USUALL

0 · Reply

hBarbarism Jan. 28 at 8:51 PM

$BHST Yes partnership with Gatorade , Let’s goo

0 · Reply

sepsis74 Jan. 28 at 2:17 PM

$BHST all good news, but the stock is languishing.

1 · Reply

mankind1 Jan. 28 at 1:05 AM

$BHST I was thinking... these drinks and chewables can be really big. I'd imagine Gatorade would be interested in working with them.

0 · Reply

OfficialStocktwitsUser Jan. 25 at 3:30 AM

0 · Reply

mankind1 Jan. 8 at 5:12 PM

$BHST somebody give me something to think about

1 · Reply

mankind1 Jan. 7 at 8:44 PM

$BHST getting some attention

0 · Reply

BioHarvest_Sciences Jan. 7 at 4:42 PM

0 · Reply

newsfile_corp Jan. 7 at 12:31 PM

https://nfne.ws/279690 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #AnnualResults #NASDAQ #In

0 · Reply

mankind1 Jan. 5 at 6:43 AM

$BHST consolidation?

2 · Reply

forgottenchuck Jan. 2 at 6:50 PM

$BHST i cannot no longer trade bioharvest on charles schwab anymore. they call the stock a risk

1 · Reply

OfficialStocktwitsUser Dec. 26 at 7:17 PM

$BHST RSI: 33.69, MACD: -0.5490 Vol: 0.50, MA20: 5.79, MA50: 7.49 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

CitadelCurator Dec. 26 at 5:14 PM

$BHST Conditions are shifting toward markets rewarding operational proof over narrative ambition. Operating rhythm should stabilize as learning cycles compress. Demonstrated durability would lengthen investor time horizons. Sentiment should follow consistency rather than noise.

0 · Reply

TheDealerDeck Dec. 24 at 12:31 PM

$BHST Investor conviction will hinge on whether internal discipline offsets macro and competitive headwinds. Confidence improves only with repeatable results.

0 · Reply

mankind1 Dec. 24 at 6:14 AM

$BHST I want that drink!

1 · Reply

SuperGreenToday Dec. 22 at 9:38 PM

$BHST

0 · Reply

BioHarvest_Sciences Dec. 18 at 4:14 PM

$BHST News Release--> BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform. The grant will be used to accelerate: - Integration of artificial intelligence–based tools for process optimization, data analytics, and real-time decision-making - Significant increases in bioreactor size, supporting higher-volume production and improved unit economics - Expanded autonomous manufacturing functions, enhancing scalability, reproducibility, and operational efficiency Read the full news release: https://ir.bioharvest.com/press-releases/

0 · Reply

Conjugation Dec. 18 at 12:54 PM

$BHST BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform

0 · Reply

newsfile_corp Dec. 18 at 12:32 PM

https://nfne.ws/278495 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing

0 · Reply

mankind1 Dec. 17 at 5:42 PM

$BHST buy at this price

0 · Reply

stockrandd Dec. 16 at 10:14 PM

$MRNA $VRTX $DHR $TNXP Have you heard about $BHST Are you Bullish? https://www.youtube.com/watch?v=VCRFmrw7nhQ

0 · Reply

Market Cap	80.65M
Revenue (ttm)	25.19M
Net Income (ttm)	-12.91M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-51.25%
Debt to Equity Ratio	0.78

Volume	23,400
Avg Vol	53,450
Day's Range	N/A - N/A
Shares Out	16.43M
Stochastic %K	7%
Beta	1.12
Analysts	Strong Sell
Price Target	$13.67